ProfileGDS4718 / 218024_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 99% 98% 97% 98% 98% 95% 96% 98% 98% 98% 98% 98% 98% 95% 97% 98% 98% 95% 95% 94% 98% 98% 99% 99% 98% 96% 98% 94% 98% 96% 96% 96% 98% 99% 96% 97% 95% 98% 98% 96% 98% 96% 96% 94% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]12.075499
GSM549102patient 115, normal, homogenized [OPG study]11.679798
GSM549104patient 119, normal, homogenized [OPG study]10.848797
GSM549108patient 138, normal, homogenized [OPG study]11.627598
GSM549119patient 077, normal, homogenized [OPG study]11.718998
GSM549133patient 032, cancer, homogenized [OPG study]10.22295
GSM549139patient 042, cancer, homogenized [OPG study]10.619696
GSM549099patient 107, normal, homogenized [OPG study]11.629798
GSM549109patient 139, normal, homogenized [OPG study]11.38798
GSM549110patient 046, normal, homogenized [OPG study]11.967898
GSM549114patient 063, normal, homogenized [OPG study]11.878998
GSM549122patient 082, normal, homogenized [OPG study]11.577198
GSM549134patient 033, cancer, homogenized [OPG study]11.303198
GSM549136patient 036, cancer, homogenized [OPG study]10.22495
GSM549140patient 044, cancer, homogenized [OPG study]10.75997
GSM549111patient 047, normal, homogenized [OPG study]11.414598
GSM549113patient 057, normal, homogenized [OPG study]11.9598
GSM549132patient 031, cancer, homogenized [OPG study]10.276595
GSM549137patient 038, cancer, homogenized [OPG study]10.171995
GSM549142patient 047, cancer, homogenized [OPG study]9.4488894
GSM549100patient 110, normal, homogenized [OPG study]11.754798
GSM549107patient 135, normal, homogenized [OPG study]11.930398
GSM549115patient 068, normal, homogenized [OPG study]12.097299
GSM549116patient 072, normal, homogenized [OPG study]12.03899
GSM549120patient 078, normal, homogenized [OPG study]11.565898
GSM549131patient 030, cancer, homogenized [OPG study]10.408496
GSM549118patient 074, normal, homogenized [OPG study]11.613198
GSM549129patient 027, cancer, homogenized [OPG study]9.8507894
GSM549123patient 088, normal, homogenized [OPG study]11.880898
GSM549124patient 006, cancer, homogenized [OPG study]10.386296
GSM549126patient 015, cancer, homogenized [OPG study]10.283396
GSM549128patient 025, cancer, homogenized [OPG study]10.328496
GSM549103patient 117, normal, homogenized [OPG study]11.497398
GSM549117patient 073, normal, homogenized [OPG study]12.053399
GSM549138patient 041, cancer, homogenized [OPG study]10.552596
GSM549141patient 045, cancer, homogenized [OPG study]10.723597
GSM549130patient 028, cancer, homogenized [OPG study]10.02695
GSM549101patient 111, normal, homogenized [OPG study]11.120998
GSM549105patient 128, normal, homogenized [OPG study]11.670598
GSM549106patient 134, normal, homogenized [OPG study]10.576896
GSM549112patient 048, normal, homogenized [OPG study]12.011998
GSM549125patient 011, cancer, homogenized [OPG study]10.512196
GSM549127patient 024, cancer, homogenized [OPG study]10.359496
GSM549135patient 035, cancer, homogenized [OPG study]10.084394